A multicenter French study, recently published in JAMA Dermatology, has shed light on a potential new application for GLP-1 receptor agonistscommonly prescribed for type 2 diabetes and weight lossin the management of hidradenitis suppurativa (HS), a chronic and often debilitating inflammatory skin disease
Notably, although there was not a statistically significant increase in biliary disease among GLP-1 receptor agonist users in this study, the FDA 2 added warnings and precautions about acute cholecystitis and biliary disease to the label in late 2022 based on data from placebo-controlled RCTs as well as other observational data 3
However, if blood sugar levels drop too low, a person may develop a severe medical condition called hypoglycemia
N-acetyl cysteine as an adjunct in the treatment of tuberculosis
DSouza R, Horyn I, Pavalagantharajah S, Zaffar N, Jacob CE
It mimics a natural hormone called GLP-1